From 1016 opportunities to ΔG-visualization in the binding site

webinar

Thu, 26 Oct 2017, 14:00 CEST (Berlin)

Dr. Christian Lemmen, BioSolveIT GmbH, St. Augustin, Germany

From 1016 opportunities to ΔG-visualization in the binding site

Taking “the best of both worlds” is usually desirable but rarely achieveable in real life. In drug discovery it is worse: many solutions — so many choices — but no one software can handle all challenges equally well.
Workflow systems like KNIME® offer you a single interface to a myriad of tools and help you to organize, standardize, and streamline your approach and be best prepared all along the way from 1016 opportunities to visualizing atom-based ΔG-contributions in the binding site. We will show you a number of highly efficient strategies implemented this way. Plus you’ll get those as a blue print for your own solution.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on